Skip to main content
. 2019 May 2;8(6):2942–2949. doi: 10.1002/cam4.2201

Table 4.

Multiple Cox's regression model for the association with overall survival for patients with chronic myeloid leukemia treated at the National Cancer Institute – Mexico (2000‐2016, N = 411, 95% confidence interval [CI])

Variable β 95% CI P‐value
Initial phase 0.447 (0.088, 0.806) 0.015
Hasforda 0.369 (0.049, 0.688) 0.024
Hematological response at 3 mo 0.717 (0.443, 0.991) <0.001
a

Similar results were observed when the Sokal risk score was included in the model.